- Home
- LGVN vs WATT Comparison
LGVN vs WATT Comparison
Compare LGVN & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- WATT
- Stock Information
- Founded
- LGVN 2014
- WATT 2012
- Country
- LGVN United States
- WATT United States
- Employees
- LGVN N/A
- WATT N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- LGVN Health Care
- WATT Technology
- Exchange
- LGVN Nasdaq
- WATT Nasdaq
- Market Cap
- LGVN 23.4M
- WATT 9.9M
- IPO Year
- LGVN 2021
- WATT 2014
- Fundamental
- Price
- LGVN $1.31
- WATT $0.28
- Analyst Decision
- LGVN Strong Buy
- WATT
- Analyst Count
- LGVN 3
- WATT 0
- Target Price
- LGVN $8.67
- WATT N/A
- AVG Volume (30 Days)
- LGVN 134.8K
- WATT 594.3K
- Earning Date
- LGVN 08-13-2025
- WATT 08-07-2025
- Dividend Yield
- LGVN N/A
- WATT N/A
- EPS Growth
- LGVN N/A
- WATT N/A
- EPS
- LGVN N/A
- WATT N/A
- Revenue
- LGVN $2,225,000.00
- WATT $1,047,000.00
- Revenue This Year
- LGVN N/A
- WATT $1,028.91
- Revenue Next Year
- LGVN $51.48
- WATT N/A
- P/E Ratio
- LGVN N/A
- WATT N/A
- Revenue Growth
- LGVN 127.50
- WATT 137.41
- 52 Week Low
- LGVN $1.14
- WATT $0.12
- 52 Week High
- LGVN $6.40
- WATT $2.70
- Technical
- Relative Strength Index (RSI)
- LGVN 51.52
- WATT 50.65
- Support Level
- LGVN $1.27
- WATT $0.26
- Resistance Level
- LGVN $1.40
- WATT $0.30
- Average True Range (ATR)
- LGVN 0.09
- WATT 0.02
- MACD
- LGVN 0.01
- WATT 0.00
- Stochastic Oscillator
- LGVN 50.00
- WATT 60.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.